Impact of the COVID-19 pandemic on care for patients with atrial fibrillation
Pandemic Disruptions of Atrial Fibrillation Care
This study looks at how the COVID-19 pandemic has changed the way people with atrial fibrillation (AF) receive care, including how their diagnosis and treatment have been affected, and it also checks if using telemedicine helped them stay on track with their health during this tough time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10893608 on NIH RePORTER |
What this research studies
This research investigates how the COVID-19 pandemic has affected the care and management of patients with atrial fibrillation (AF), a heart condition that increases the risk of stroke. It aims to understand the disruptions in diagnosis, treatment initiation, and adherence to anticoagulation therapy during the pandemic. By analyzing claims data from Medicare and commercial insurance, the study will assess whether these disruptions have worsened health outcomes and disparities among AF patients. Additionally, it will explore the role of telemedicine in maintaining care during these challenging times.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with atrial fibrillation, particularly those who may have experienced disruptions in their care due to the COVID-19 pandemic.
Not a fit: Patients who do not have atrial fibrillation or those whose care has not been affected by the pandemic may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for managing atrial fibrillation care during public health crises, ultimately reducing the risk of stroke for patients.
How similar studies have performed: Other research has indicated that public health crises can significantly impact chronic disease management, suggesting that this study's approach is relevant and necessary.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Patel, Nimish — University of California, San Diego
- Study coordinator: Patel, Nimish
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.